LY03004
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LY03004, covering 2014-11-10 to 2015-06-18. Get the full timeline:
Most recent: Clinical Trial Update: An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]